Medicine and Dentistry
Patient
100%
Therapeutic Procedure
76%
Bortezomib
68%
Neuropathy
49%
Oxaliplatin
45%
Neurotoxicity
43%
Glioblastoma
39%
Peripheral Neuropathy
32%
Neuron
27%
Brain
25%
Multiple Myeloma
24%
Epileptic Seizure
23%
Chemotherapeutic Agent
23%
Adverse Event
23%
Proteasome Inhibitor
22%
Chemotherapy
19%
Malignant Neoplasm
18%
Anticarcinogen
18%
Development
16%
Survival
16%
Cells
15%
Combination Therapy
12%
Dorsal Root
12%
Drug
11%
Toxicity
11%
Incidence
11%
Immunoglobulin Enhancer Binding Protein
11%
Ganglion
11%
Chemotherapy-Induced Peripheral Neuropathy
10%
Autonomic Nervous System
10%
Quantitative Sensory Testing
10%
Cisplatin
10%
Computer-Aided Design
10%
Gray Matter
10%
Blood Brain Barrier
10%
Nanoparticle
10%
Inpatient
9%
Analysis
8%
Radiation Therapy
8%
Cerebrospinal Fluid
8%
Interleukin-6
8%
Cancer Therapy
8%
Transitional Cell Carcinoma
7%
Small Cell Lung Cancer
7%
Autonomic Neuropathy
7%
Meningeal Carcinomatosis
7%
Anticonvulsant
7%
White Matter
7%
Pharmacogenetics
7%
Hazard Ratio
7%
Pharmacology, Toxicology and Pharmaceutical Science
Bortezomib
68%
Neuropathy
52%
Glioblastoma
51%
Peripheral Neuropathy
36%
Neurotoxicity
31%
Oxaliplatin
26%
Multiple Myeloma
24%
Chemotherapy
23%
Adverse Event
23%
Chemotherapy-Induced Peripheral Neuropathy
23%
Proteasome Inhibitor
22%
Anticarcinogen
22%
Malignant Neoplasm
21%
Cisplatin
21%
Nanoparticle
16%
Side Effect
15%
Survival
15%
Drug
15%
Toxicity
12%
Catechol
12%
Taxane
12%
Immunoglobulin Enhancer Binding Protein
11%
Neoplasm
10%
Seizure
10%
Blood-Brain Barrier
10%
Incidence
9%
Colorectal Cancer
9%
Platinum
9%
Mouse
9%
Animal
8%
Brain Tumor
8%
Carcinomatous Meningitis
7%
Autonomic Neuropathy
7%
Small Cell Lung Cancer
7%
Anticonvulsive Agent
7%
Immune Checkpoint Inhibitor
6%
Symptom
6%
Neuropathic Pain
6%
Complication
6%
Mouse Model
6%
Pain
6%
Gossypol
5%
Clinical Feature
5%
Pathophysiology
5%
Protein
5%
Clinical Trial
5%
Epilepsy
5%
Transthyretin
5%
Normal Human
5%
Neuroscience
Bortezomib
68%
Peripheral Neuropathy
63%
Peripheral Neuropathy
60%
Chemotherapy
56%
Oxaliplatin
52%
Neurotoxicity
48%
Seizure
23%
Proteasome Inhibitor
22%
Cisplatin
14%
Dorsal Root Ganglion
12%
Sensory Neuron
12%
Taxane
12%
Immunoglobulin Enhancer Binding Protein
11%
Autonomic Neuropathy
7%
Meningeal Carcinomatosis
7%
Anticonvulsant
7%
Peripheral Nerve
7%
Glioblastoma Multiforme
7%
Neuropathic Pain
6%
Gossypol
5%
Voltage-Gated Potassium Channels
5%
CAG Repeat
5%
DNA Damage
5%
Magnetic Resonance Imaging
5%
Adverse Effect
5%
Nerve Growth Factor
5%
Schwann Cell
5%
Transthyretin
5%
Epilepsy
5%
Antineoplastic Drugs
5%